Copyright
©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 697-702
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.697
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.697
Table 4 Multivariate analysis of factors associated with graft loss
| Variable | Hazard ratio | 95%CI | P-value |
| CNI tacrolimus | 0.74 | 0.58-0.94 | 0.012 |
| History of DM | 1.41 | 1.13-1.76 | 0.002 |
| History of HTN | 0.56 | 0.34-0.94 | 0.029 |
| Delayed graft function | 2.1 | 1.66-2.66 | < 0.001 |
| Acute rejection | 1.59 | 1.26-2.01 | < 0.001 |
- Citation: Kamel M, Kadian M, Srinivas T, Taber D, Posadas Salas MA. Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine. World J Transplant 2016; 6(4): 697-702
- URL: https://www.wjgnet.com/2220-3230/full/v6/i4/697.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i4.697